Dov Konetz
On July 18, 2024, Dov Konetz tendered his resignation as a director of Limitless X Holdings Inc. (the “Company”), effective immediately.
Highest-materiality recent filing
Limitless X exchanges insider-held Class C preferred for Series D 15% perpetual preferred
Exchanged 304,264 Class C convertible preferred shares for 1,264,365 Series D 15% cumulative redeemable perpetual preferred shares.
Limitless X enters binding LOI to acquire 60% of Ding Easy AI for $9M in stock
Bodycor, subsidiary of Limitless X, to acquire 60% of Ding Easy AI at $15M pre-money valuation; consideration of $9M in LIMX restricted stock.
Limitless X enters lease for Manny Pacquiao center and raises $675k through convertible notes
Lease: 3,815 sq ft in LA for Manny Pacquiao training center; 5-year term starting Feb 2026; rent $14,306-$16,214/mo plus 3% annual escalations; guaranteed by Company and CEO Jas Mathur.
Limitless X names Daniel Sanders President; highlights retail and manufacturing expertise
Daniel Sanders appointed President effective Jan 4, 2026; will oversee manufacturing, supply chain, retail expansion.
Regulation A Tier 2 Offering qualified by SEC; new perpetual preferred stock (LIMXP) pays 15% annual dividend.
Limitless X converts $6.5M debt owed to CEO into 260K Series D preferred shares
Converted $6,505,368 aggregate debt (principal + interest) owed to CEO Jaspreet Mathur and two controlled entities.
Errors in accounts receivable collectability, holdback receivables, and inventory; corrections filed in amended 10-K and 10-Q.
CEO loans $500K to Limitless X at 12.5% interest, receives common and preferred stock
Company borrows $500,000 from CEO Jaspreet Mathur at 12.5% fixed interest; total repayment $562,500.
Limitless X converts $3.375M debt to Series D Preferred; signs Pauly D endorsement for $250K/year
Debt conversion with CEO Jaspreet Mathur: $3M principal + $375K interest settled by issuing 135K shares of Series D 15% Cumulative Preferred.
Limitless X enters consulting deal with CEO affiliate, designates Series D preferred stock
Entered consulting agreement with CEO-owned Limitless Performance Inc.; grant of 133,333 stock options as compensation.
Issued 1.34M common shares to five employees to settle $536K in unpaid wages for Sep–Dec 2024.
Limitless X Holdings releases shareholder letter detailing expansion into new divisions and products
CEO Jas Mathur plans to reconnect with 11 million social media followers to invite them as LIMX equity holders.
Limitless X settles compensation disputes with key employees, issuing 3.2M shares
Issued aggregate of 3,202,464 shares of common stock to settle disputed unpaid wages with four employees.
Limitless X replaces BF Borgers with M&K CPAS after SEC bars former auditor
Dismissed BF Borgers CPA PC effective May 9, 2024; engaged M&K CPAS, PLLC as new auditor.
Limitless X terminates four license agreements with key licensors effective Oct 1, 2023
Entered four Termination Agreements with Limitless Performance, Amarose, Divatrim, and SMILZ, Inc. on Nov 1, 2023.
Limitless X converts $9.675M in convertible notes to Class B Preferred Stock
Converted $9,675,000 principal plus $674,097 accrued interest into 10,349,097 shares of Class B Preferred Stock.
Limitless X sells Vybe Labs to CEO-owned entity for debt settlement; CEO commits $1M working capital
Sold all 5,000 shares of Vybe Labs to CEO-owned Emblaze One in full settlement of $1,167,011 debt.
Limitless X Holdings adopts amended bylaws with supermajority and exclusive forum provisions
Board granted exclusive authority to call special meetings; quorum set at 33.33% of voting shares.
Amendment No. 1 removes Sections 3.5 and 3.6, which prohibited equity sales below $0.40/share and reverse stock splits for 12 months post-closing.
Bio Lab Naturals receives $500k CEO advance; name change to Limitless X Holdings Inc.
CEO Jaspreet Mathur advanced $500k on June 1, 2022; total advances $2.8M at 6%-8.5% interest.
Bio Lab Naturals completes acquisition of LimitlessX, issuing 97 million shares
Issued 97 million shares to LimitlessX shareholders on May 20, 2022, with additional 9 million due within six months.
Bio Lab Naturals will acquire all of Limitless X (health/wellness, beauty, CBD) via share exchange.
On July 18, 2024, Dov Konetz tendered his resignation as a director of Limitless X Holdings Inc. (the “Company”), effective immediately.
On January 11, 2023, the Board appointed Hassan Iddrissu and Michael Braun to fill the two vacancies.
On January 11, 2023, the Board appointed Hassan Iddrissu and Michael Braun to fill the two vacancies.
On October 3, 2022, the Board appointed Dan Fleyshman and Leon Anderson to fill the two vacancies.
On October 3, 2022, the Board appointed Dan Fleyshman and Leon Anderson to fill the two vacancies.
Benjamin Chung was appointed as Chief Financial Officer
Bharat Raj Mathur, age 67, became a director of the Company on May 20, 2022.
W. Edward Nichols, Darrell Avey, Jeremy Ostler and Calvin D. Smiley, Sr. resigned as officers and directors of the Company.
Amanda Saccomanno, age 31, became a director of the Company on May 20, 2022.
W. Edward Nichols, Darrell Avey, Jeremy Ostler and Calvin D. Smiley, Sr. resigned as officers and directors of the Company.
W. Edward Nichols, Darrell Avey, Jeremy Ostler and Calvin D. Smiley, Sr. resigned as officers and directors of the Company.
Jaspreet Mathur was appointed as the Company’s Chairman and Chief Executive Officer
Max materiality 1.00 · Median 0.60 · Most common event other_material